MedPath

ROLE OF 25% DEXTROSE PROLOTHERAPY VERSUS EXTRA CORPOREAL SHOCKWAVE therapy in the treatment of chronic lateral epicondylitis

Not Applicable
Conditions
Health Condition 1: M771- Lateral epicondylitis
Registration Number
CTRI/2019/10/021802
Lead Sponsor
DEBASISH DEB
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Duration of symptoms for at least 6 months

Failed conservative treatment

Willingness to comply with treatment and

follow-up assessment

Exclusion Criteria

Duration of symptoms less than 6 months

History of previous surgery in the same tendon

Implanted hardware adjacent to the target treatment region

Abnormal radiographic findings like Osteophtyes, Calcification, or Exostosis

pregnancy

Diabetes

Cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
improvement in pain in terms of VAS <br/ ><br>improvement in functional outcome in terms of Grip strengthTimepoint: BASELINE, 1MONTH, 3MONTH, 6MONTH
Secondary Outcome Measures
NameTimeMethod
grip srtength assessmentTimepoint: at baseline, 1month,3 month, 6month
© Copyright 2025. All Rights Reserved by MedPath